Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

Authors: Qing Zhou, Chong‐Rui Xu, Ying Cheng, Yunpeng Liu, Gongyan Chen, Jiuwei Cui, Nong Yang, Yong Song, Xiaoling Li, Shun Lü, Jianying Zhou, Zhiyong Ma, Shiying Yu, Cheng Huang, Yongqian Shu, Zhen Wang, Jin‐Ji Yang, Hai‐Yan Tu, Wen‐Zhao Zhong, Yi‐Long Wu - Cancer Cell 2021 cited by 228